Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. Keeping that in mind, here are three stocks where Wall Street’s positive outlook is supported by strong fundamentals.
Coinbase (COIN)
Consensus Price Target: $231.79 (33.5% implied return)
Widely regarded as the face of crypto, Coinbase (NASDAQ: COIN) is a blockchain infrastructure company updating the financial system with its trading, staking, stablecoin, and other payment solutions.
Why Is COIN Interesting?
- Impressive 28.5% annual revenue growth over the last two years indicates it’s winning market share
- Prominent and differentiated platform culminates in a best-in-class gross margin of 85.9%
- COIN is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders
At $173.56 per share, Coinbase trades at 17.2x forward EV/EBITDA. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
iRhythm (IRTC)
Consensus Price Target: $180.93 (66% implied return)
Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ: IRTC) provides wearable cardiac monitoring devices and AI-powered analysis services that help physicians detect and diagnose heart rhythm disorders.
Why Does IRTC Catch Our Eye?
- Market share has increased this cycle as its 23.9% annual revenue growth over the last two years was exceptional
- Additional sales over the last five years increased its profitability as the 27.5% annual growth in its earnings per share outpaced its revenue
- Free cash flow profile has moved into positive territory over the last five years, indicating the company has passed a significant test
iRhythm is trading at $109.00 per share, or 326.4x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Cigna (CI)
Consensus Price Target: $341.50 (20.7% implied return)
With roots dating back to 1792 and serving millions of customers across the globe, The Cigna Group (NYSE: CI) provides healthcare services through its Evernorth Health Services and Cigna Healthcare segments, offering pharmacy benefits, specialty care, and medical plans.
Why Could CI Be a Winner?
- 16.1% annual revenue growth over the last two years surpassed the sector average as its offerings resonated with customers
- Unparalleled scale of $277.7 billion in revenue enables it to spread administrative costs across a larger membership base
- Earnings per share grew by 10.9% annually over the last five years, comfortably beating the peer group average
Cigna’s stock price of $283.00 implies a valuation ratio of 9.1x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
